Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Lidocaine recalled?

Yes — there is an active recall. 61 ongoing FDA recalls mention Lidocaine (366 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Lidocaine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Lidocaine recalls on record

none so far in 2026; 366 on record, newest first
Class II · Moderate risk

PRE-TAT (lidocaine)

Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Terminated Microbial contamination Ridge Properties, LLC NDC 69804-002-05 D-1856-2019
Class II · Moderate risk

Workvie Instant Pain Relieving Roll On

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 72393-201-25 D-1507-2019
Class II · Moderate risk

Lid O Creme

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-111-25 D-1502-2019
Class II · Moderate risk

Lido E.R. (Lidocaine HCL 4%)

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-115-04 D-1501-2019
Class II · Moderate risk

LidoAID (Lidocaine HCL 4%)

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-114-04 D-1499-2019
Class II · Moderate risk

Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJ

Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Terminated Sterility / contamination Premier Pharmacy Labs Inc D-1419-2019
Class II · Moderate risk

Heparin 20

Lack of sterility assurance.

Terminated Sterility / contamination Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1156-2019
Class II · Moderate risk

Pge1-Lidocaine 40 Mcg-1% /Ml* Injectable

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Terminated Sterility / contamination Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy D-1098-2019
Class II · Moderate risk

LET Gel 4%

Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.

Terminated Labeling / mix-up US Compounding Inc D-0482-2019